State of Michigan Retirement System’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,510
Closed -$204K 976
2022
Q2
$204K Buy
+4,510
New +$234K ﹤0.01% 969
2021
Q2
Sell
-3,762
Closed -$681K 984
2021
Q1
$681K Buy
+3,762
New +$650K ﹤0.01% 957
2020
Q4
Sell
-4,358
Closed -$543K 976
2020
Q3
$543K Buy
+4,358
New +$457K ﹤0.01% 912
2020
Q2
Sell
-4,570
Closed -$285K 957
2020
Q1
$285K Buy
+4,570
New +$357K ﹤0.01% 901

Other funds holding TXG

State of Michigan Retirement System's TXG Position: Q3 2022 in Review

State of Michigan Retirement System sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 4,510 shares — an estimated $204K sold.

State of Michigan Retirement System first reported a position in TXG in Q1 2020 and held it in 4 quarters. The position peaked at $681K in Q1 2021. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • State of Michigan Retirement System reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
  • State of Michigan Retirement System sold 4,510 10x Genomics shares in Q3 2022, an estimated $204K.
  • State of Michigan Retirement System first reported a position in 10x Genomics in Q1 2020 and held it in 4 quarters.
  • State of Michigan Retirement System's 10x Genomics position peaked at $681K in Q1 2021.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on State of Michigan Retirement System's 13F filing for Q3 2022, filed 24 Oct 2022.